Plato Investment Management Ltd Acquires 510 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Plato Investment Management Ltd boosted its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 87.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,095 shares of the medical instruments supplier’s stock after buying an additional 510 shares during the period. Plato Investment Management Ltd’s holdings in Mettler-Toledo International were worth $1,345,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. SBI Securities Co. Ltd. purchased a new stake in Mettler-Toledo International during the 4th quarter valued at $33,000. Jones Financial Companies Lllp raised its stake in Mettler-Toledo International by 54.9% during the 4th quarter. Jones Financial Companies Lllp now owns 175 shares of the medical instruments supplier’s stock valued at $214,000 after buying an additional 62 shares during the last quarter. SRS Capital Advisors Inc. raised its stake in Mettler-Toledo International by 43.8% during the 4th quarter. SRS Capital Advisors Inc. now owns 69 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 21 shares during the last quarter. Jacobi Capital Management LLC raised its stake in Mettler-Toledo International by 9.1% during the 4th quarter. Jacobi Capital Management LLC now owns 180 shares of the medical instruments supplier’s stock valued at $220,000 after buying an additional 15 shares during the last quarter. Finally, Metis Global Partners LLC raised its stake in Mettler-Toledo International by 6.1% during the 4th quarter. Metis Global Partners LLC now owns 1,945 shares of the medical instruments supplier’s stock valued at $2,380,000 after buying an additional 112 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Stock Down 0.3 %

MTD opened at $1,269.44 on Tuesday. The firm has a 50-day simple moving average of $1,291.90 and a two-hundred day simple moving average of $1,327.92. Mettler-Toledo International Inc. has a 52 week low of $1,142.91 and a 52 week high of $1,546.93. The company has a market capitalization of $26.55 billion, a PE ratio of 31.32, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, sell-side analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christian Magloth sold 790 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Wall Street Analysts Forecast Growth

MTD has been the subject of a number of research reports. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Robert W. Baird upped their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Wolfe Research started coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Evercore ISI upped their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $1,368.00.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.